DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (56)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 56   Next >>

Possible Herceptin side effects in 63 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Malaise, Neutropenic Sepsis, Pain, Necrotising Fasciitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer Stage I

Docetaxel
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30
    End date: 2010-05-24

Docetaxel
    Dosage: dose reduced,third dose not given.

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Dexamethasone; Epirubicin; Tinzaparin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Argentina on 2012-08-20

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Muscle Contracture, Headache, Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium



Possible Herceptin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-15

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Pain, Neutropenic Sepsis, Necrotising Fasciitis, Mobility Decreased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer Stage I
    Start date: 2010-05-21

Docetaxel
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30

Docetaxel
    Dosage: 75 mg/m2, unk
    End date: 2010-05-25

Other drugs received by patient: Tinzaparin; Epirubicin; Dexamethasone; Fluorouracil; Cyclophosphamide



Possible Herceptin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-07

Patient: male, weighing 82.2 kg (180.8 pounds)

Reactions: White Blood Cell Count Decreased, Hepatic Mass, Blood Pressure Increased, Fatigue, Arthralgia, Eosinophil Count Increased, Lymphocyte Count Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin
    Start date: 2011-07-22

Herceptin
    Start date: 2011-02-09

Herceptin
    Start date: 2011-06-01

Herceptin
    Start date: 2011-06-22

Herceptin
    Start date: 2011-08-10

Herceptin
    Indication: Metastatic Gastric Cancer
    Start date: 2011-01-19

Other drugs received by patient: Avalide; Pantoprazole; Senokot; Avalide; Docusate; Pantoprazole Sodium; Dilaudid; Solucort



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-03

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB



Possible Herceptin side effects in 69 year old female

Reported by a physician from Spain on 2012-07-24

Patient: 69 year old female

Reactions: Forced Expiratory Volume Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Sepsis, Haemorrhage Intracranial, Hypotension, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: female, weighing 65.8 kg (144.8 pounds)

Reactions: Neuropathy Peripheral, Nausea, Blindness Unilateral

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Sepsis, Haemorrhage Intracranial, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06



Possible Herceptin side effects in 65 year old female

Reported by a physician from Hong Kong on 2012-07-11

Patient: 65 year old female

Reactions: Central Nervous System Lesion, Coordination Abnormal, Disease Progression, Eating Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-09

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Haemorrhage Intracranial, Sepsis, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06



Possible Herceptin side effects in 68 year old female

Reported by a physician from China on 2012-07-03

Patient: 68 year old female

Reactions: Myocardial Infarction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-02

Patient: female, weighing 88.0 kg (193.6 pounds)

Reactions: Myalgia, Osteonecrosis, Hepatobiliary Disease, Femur Fracture, Arthralgia, Musculoskeletal Pain, Spinal Osteoarthritis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zometa
    Indication: Product Used FOR Unknown Indication
    End date: 2009-06-03

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2005-09-19



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Haemorrhage Intracranial, Hypotension, Sepsis, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-15

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin



Possible Herceptin side effects in 60 year old male

Reported by a physician from Germany on 2012-06-11

Patient: 60 year old male, weighing 90.0 kg (198.0 pounds)

Reactions: Bicuspid Aortic Valve, Aortic Aneurysm

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid



Possible Herceptin side effects in female

Reported by a physician from France on 2012-06-07

Patient: female

Reactions: Dysgeusia, Rash Papular, Palmar-Plantar Erythrodysaesthesia Syndrome, Epistaxis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer

Taxotere
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-03-21



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-07

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid



Possible Herceptin side effects in 60 year old male

Reported by a physician from Germany on 2012-05-23

Patient: 60 year old male, weighing 90.0 kg (198.0 pounds)

Reactions: Bicuspid Aortic Valve, Aortic Aneurysm

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-09

Patient: female

Reactions: Tinnitus, Deafness, Headache

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in 60 year old male

Reported by a physician from Switzerland on 2012-04-24

Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Osteonecrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-01

Zometa
    Indication: Bone Neoplasm
    Start date: 2009-06-16
    End date: 2012-02-09

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2010-03-09

Carboplatin
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxotere
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxol
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Other drugs received by patient: Neulasta



Possible Herceptin side effects in 60 year old male

Reported by a consumer/non-health professional from Switzerland on 2012-04-24

Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Osteonecrosis, Aneurysm

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zometa
    Dosage: intrp and reintiated,last dose on 09feb12 again suspended
    Indication: Neoplasm Malignant
    Start date: 2009-06-16
    End date: 2012-02-09

Herceptin
    Indication: Breast Cancer
    Start date: 2011-11-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Carboplatin
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxotere
    Indication: Breast Cancer
    Start date: 2011-11-01

Taxol
    Indication: Breast Cancer
    Start date: 2010-03-09
    End date: 2011-02-14

Other drugs received by patient: Neulasta



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11

Patient: female

Reactions: Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Auy922
    Indication: Breast Cancer

Herceptin
    End date: 2011-04-01

Herceptin
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-04-10

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Fluconazole; Tinzaparin; Vitamin K TAB; Ciprofloxacin Hydrochloride; Omeprazole; Mucosta



Possible Herceptin side effects in female

Reported by a physician from France on 2012-04-10

Patient: female

Reactions: Alopecia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Taxotere
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-10-22
    End date: 2007-12-03

Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-02-11
    End date: 2009-01-16

Herceptin
    Start date: 2010-12-01

Paclitaxel
    Start date: 2011-02-08
    End date: 2011-05-24

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-01
    End date: 2011-01-01

Paclitaxel
    Dosage: drug: paclitaxel ebewe
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-10
    End date: 2011-02-01

Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Cyclophosphamide
    Dosage: drug: paclitaxel hospira
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Arimidex
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-03-01



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-04-05

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Vitamin K TAB; Mucosta; Fluconazole; Tinzaparin; Omeprazole; Ciprofloxacin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014